| Annual Financials | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 42 | 40 | 43 | 48 | 0 |
| Expenses | 32 | 32 | 34 | 40 | 0 |
| EBITDA | 9 | 7 | 9 | 9 | 0 |
| Operating Profit % | 22 % | 19 % | 20 % | 17 % | 0 % |
| Depreciation | 0 | 1 | 1 | 2 | 0 |
| Interest | 0 | 0 | 1 | 1 | 0 |
| Profit Before Tax | 9 | 7 | 7 | 6 | 0 |
| Tax | 2 | 2 | 2 | 2 | 0 |
| Net Profit | 7 | 5 | 5 | 4 | 0 |
| EPS in ₹ | 6.91 | 4.90 | 5.36 | 4.03 | 0.00 |
Shanmuga Hospital
Shanmuga Hospital
48.42
+0.09
(0.19%)
Market Cap
₹66.90 Cr
PE Ratio
15.91
Volume
10,000.00
Day High - Low
₹50.00 - ₹48.42
52W High-Low
₹54.90 - ₹31.00
Key Fundamentals
Market Cap
66.90 Cr
EPS
4.03
PB Ratio
1.69
Book Value
29.16
EBITDA
8.50
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals ROE Growth %
-
Debt to Equity
0.29
Actual
Company News
View All News
Shanmuga Hospital Limited Reports Full Utilization of IPO Proceeds Worth Rs 2,061.72 Lakhs
Nov 13, 2025
Nov 13, 2025Shanmuga Hospital Limited filed a statement confirming no deviations in the utilization of IPO proceeds during the half year ended September 30, 2025. The company raised Rs 2,061.72 lakhs through its IPO with allotment date of February 18, 2025. The opening unutilized IPO proceeds of Rs 1,115.50 lakhs as of March 31, 2025 were fully utilized during May 2025 for the purchase and installation of a robotic surgical machine under capital expenditure. The total IPO funds were allocated across capital expenditure (Rs 1,452.50 lakhs), issue expenses (Rs 225.94 lakhs), and general corporate purposes (Rs 383.28 lakhs). The statement was reviewed by the Audit Committee and approved by the Board on November 12, 2025. External auditors PPN and Company certified that there were no deviations in the use of public issue proceeds for the reporting period.
Shanmuga Hospital Limited announced its unaudited financial results for the half-year ended September 30, 2025. The company reported a net profit of ₹201.13 lakhs compared to ₹181.38 lakhs in the previous period and ₹239.29 lakhs in the corresponding period last year. Revenue from operations stood at ₹2,462.07 lakhs. Total expenses were ₹2,201.68 lakhs, with cost of consumption being the largest component at ₹813.05 lakhs, followed by other expenses at ₹828.12 lakhs and employee benefits expense at ₹366.76 lakhs. The company's earnings per share was ₹1.48 for both basic and diluted calculations. The company completed full utilization of its IPO proceeds of ₹2,061.72 lakhs during the reporting period, with ₹1,452.50 lakhs allocated to capital expenditure and ₹383.28 lakhs for general corporate purposes. The Board of Directors approved these results at their meeting held on November 12, 2025.
Shanmuga Hospital Limited Issues Correction to Investor Presentation for Patient Volume DataAug 11, 2025
Aug 11, 2025Shanmuga Hospital Limited has issued a correction to their investor presentation, updating the number of inpatients and outpatients. The revised presentation has been made available on the company's website. The hospital, established in 1981 and based in Salem, Tamil Nadu, operates 140 beds out of 150+ bed capacity and recently listed on BSE SME in 2025. For FY2024-25, the company reported revenue of ₹4,785.33 lakhs with 11.2% growth, though EBITDA declined 2.8% to ₹817.09 lakhs and PAT fell 19.8% to ₹420.67 lakhs. The hospital handled 25,440 inpatients and 43,053 outpatients with an average occupancy rate of 49.78%. The company has strategic initiatives including launching a Nephro Care Center, adding 50 inpatient beds, and introducing renal transplant services.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,097.40 | #1 1,06,693.20 | 83.67 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 39.18 | |
7,189.50 | 1,03,374.00 | 61.72 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 30.43 | |
888.55 | 67,081.80 | 68.04 | 7,849.70 | 13.25 | 809 | 70.27 | 29.52 | |
1,916.90 | 39,173.90 | #1 48.80 | 5,575.00 | 12.29 | 790 | 30.03 | 52.81 | |
635.10 | 32,905.90 | 94.45 | 4,286.70 | 15.12 | 337 | 14.65 | 33.20 | |
1,163.50 | 31,273.80 | 58.06 | 3,771.40 | 12.59 | 481 | 21.10 | 32.67 | |
704.00 | 28,169.80 | 75.73 | 3,067.00 | 21.98 | 415 | -40.35 | 54.73 | |
506.00 | 15,997.60 | 107.45 | 1,757.00 | 27.64 | 110 | 71.36 | 47.15 | |
1,350.90 | 13,719.60 | 53.31 | 1,566.90 | 17.46 | 244 | -4.30 | 50.35 | |
720.05 | 10,152.70 | 254.74 | 2,257.70 | 17.03 | 49 | 0.00 | 46.65 |
Growth Rate
Revenue Growth
10.83 %
Net Income Growth
-19.23 %
Cash Flow Change
-231.94 %
ROE
-65.39 %
ROCE
-60.25 %
EBITDA Margin (Avg.)
-14.55 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 11 | 23 | 34 | 53 |
| Fixed Assets | 2 | 10 | 16 | 22 |
| Current Assets | 8 | 13 | 14 | 30 |
| Capital Work in Progress | 0 | 0 | 4 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 13 | 14 | 30 |
| Total Liabilities | 11 | 23 | 34 | 53 |
| Current Liabilities | 4 | 7 | 13 | 9 |
| Non Current Liabilities | 0 | 4 | 4 | 4 |
| Total Equity | 7 | 12 | 17 | 40 |
| Reserve & Surplus | 7 | 12 | 7 | 26 |
| Share Capital | 0 | 0 | 10 | 14 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 2 | -1 | -1 |
| Investing Activities | -2 | -8 | -12 | -5 |
| Operating Activities | 2 | 3 | 10 | -13 |
| Financing Activities | 0 | 7 | 1 | 16 |
Share Holding
| % Holding | Dec 2024 | Feb 2025 | Mar 2025 | Sept 2025 |
| Promoter | 71.95 % | 71.95 % | 72.11 % | 72.06 % |
| FIIs | 0.00 % | 0.00 % | 0.19 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 25.92 % | 25.92 % | 24.48 % | 24.76 % |
| Others | 2.13 % | 2.13 % | 3.22 % | 3.19 % |
| No of Share Holders | 1,772 | 9 | 1,449 | 1,156 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 May 2025 |  Quarterly Result Announcement | NA | 28 May 2025 | 38.10 | 38.50 |
| 19 Sept 2025 |  Annual General Meeting | NA | 19 Sept 2025 | 45.65 | 48.00 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 42.50 | 42.65 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation9 days ago
9 days agoStatement On Deviation Or VariationNov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for To Approve The Unaudited Financial Results For The Half Year Ended On 30Th September 2025Nov 04, 2025
Nov 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Oct 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 08, 2025
Oct 08, 2025Shanmuga Hospital Limited Honoured At Times Healthcare Achievers - Tamil Nadu 2025 For Contribution To HealthcareSep 30, 2025
Sep 30, 2025Closure Of Shanmuga ClinicsSep 30, 2025
Sep 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 25, 2025
Sep 25, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 22, 2025
Sep 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Sep 16, 2025Intimation Of Book Closure For The Purpose Of 05Th Annual General Meeting Of The Company.Sep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Aug 26, 2025Reg. 34 (1) Annual Report.Aug 25, 2025
Aug 25, 2025Notice Of The 05Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 19Th September 2025 At 03.00 P.M. Through Video Conference Or Other Audio Visual Means.Aug 25, 2025
Aug 25, 2025Intimation Regarding Commissioning And Operationalization Of PH Impedance & Manometry SystemAug 16, 2025
Aug 16, 2025Board Meeting Outcome for Outcome Of The Board Meeting
Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Aug 07, 2025Intimation Regarding Operationalization Of CT ScannerAug 06, 2025
Aug 06, 2025Board Meeting Intimation for To Fix The Date Of AGMAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Aug 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025CLOSURE OF PHARMACY UNITJun 03, 2025
Jun 03, 2025Statement On Deviation Or VariationMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2025
May 28, 2025Audited Financial Results For The Financial Year Ended 31St March 2025.May 28, 2025
May 28, 2025Board Meeting Outcome for Approval Of Audited Financial Statements For The Financial Year 2024-25May 28, 2025
May 28, 2025Board Meeting Intimation for Approving The Audited Financial Results For The Half Year / Year Ended 31St March 2025.May 21, 2025
May 21, 2025Intimation Regarding Operationalization Of Robotic Surgical EquipmentMay 11, 2025
May 11, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Apr 30, 2025Intimation About Change In CIN Of The CompanyApr 23, 2025
Apr 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements Regulations) 2015Mar 31, 2025
Mar 31, 2025Intimation Under Regulation 8(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations) For Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationMar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Mar 31, 2025Appointment of Company Secretary and Compliance OfficerMar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 24, 2025
Mar 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Mar 07, 2025
Mar 07, 2025Announcement under Regulation 30 (LODR)-Change in RTAFeb 21, 2025
Feb 21, 2025Technical Indicators
RSI(14)
Neutral 55.77
ATR(14)
Less Volatile 2.94
STOCH(9,6)
Neutral 49.40
STOCH RSI(14)
Overbought 83.60
MACD(12,26)
Bullish 0.42
ADX(14)
Weak Trend 19.92
UO(9)
Bearish 38.26
ROC(12)
Uptrend And Accelerating 23.65
WillR(14)
Neutral -40.75
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
